Merial announces PCV2 distribution agreement

Merial has announced a Toll Manufacturing and Distribution Agreement with Newport Laboratories.

In the agreement, Newport will toll manufacture and distribute Merial's autogenous porcine circovirus type 2 (PCV2) swine vaccines through Newport's veterinarian and swine integrator customer base.

These vaccines compliment Newport Laboratories' CircoSpanSM array of solution-based diagnostics, technical support, strain specific production, pinpoint formulations, and customer focused co-factor disease control consultation.

Newport Laboratories chief operations officer Randy Simonson commented that the use of Merial products and technology, along with the support of the company's sales and technical field force, will enhance the profitability of US pork producers through solution-based animal health care offerings.

Newport and Merial currently collaborate on SwiVax®-MH and Derma-Vac® NF Transdermal Needle-free Vaccination System.